USPIO-enhanced and Diffusion-weighted MRI for the Detection of Pelvic Lymph Node Metastases

Exclusion Criteria

• •Patients with contraindications for MRI (e.g. pacemaker, metal implants, claustrophobia).
• •Patients in a critical cardiovascular state, with risk of decompensation after administration of the USPIO contrast agent.
• •Patients with hemochromatosis or an allergy to dextran or iron compounds.
• •Pregnant or breast-feeding women.
• •Patients who have received gadolinium complexes within 2 days or iron oxide particles within 7 days before MRI.
• •Patients who underwent chemotherapy or radiotherapy before surgery.
• •Patients whose degree of cooperation is incompatible with carrying out the study.
• •Patients with contraindications to Glucagon administration.